Gapping down
In reaction to earnings/guidance:
- FRPT -10.9%, RIVN -7.6%, X -4.9% (guides Q4 adjusted EBITDA below consensus), SCS -3.7%, DRI -3.5%
Other news:
- FUTU -7% (responds to media report; "Futu has been abiding by the same rules and regulations and adopting the similar industry practices")
- ZME -6.7% (management changes) GM -3.1% (Cruise CEO Dan Ammann to leave the company)
- JNJ -1.9% (CDC confirms it expressed a clinical preference for individuals to receive an mRNA COVID-19 vaccine (PFE BNTX MRNA) over JNJ's COVID-19 vaccine)
- TSHA -1.6% (initiates clinical development of TSHA-118 for treatment of CLN1 disease)
- BIIB -1.6% (EMA has recommended the refusal of the marketing authorisation for Aduhelm a medicine intended for the treatment of Alzheimer's disease)
- DOV -1.5% (announces two acquisitions in clean energy)
- FB -1.2% (takes action against the surveillance-for-hire industry; says "We alerted around 50000 people who we believe were targeted by these malicious activities worldwide using the system we launched in 2015")
Analyst comments:
- SBUX -1.6% (downgraded to Neutral from Outperform at Robert W. Baird)
- CMS -1.2% (downgraded to Neutral from Buy at BofA Securities)